Kestra Medical Technologies, Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Kestra Medical Technologies, Ltd.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than almost all Healthcare companies in United States.
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $6 per $100 of sales comes from others' credit, against $53 from others' credit three years earlier. Less money tied up than 94% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Apr 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-3.2×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 58% of Healthcare companies in United States.
Cash Locked Ratio
−$6Money owed to suppliers is larger than money owed by customers plus stock: $6 per $100 of sales comes from others' credit, against $53 from others' credit three years earlier.
Less money tied up than 94% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 0/3Sales grew in 3 of the last 3 years; profit grew in 0 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
−$54Sales grew 1,147% in 3 years, but profit fell: $54 less profit per $100 of extra sales.
Lower than 83% of Healthcare companies in United States.
Asset Productivity Ratio
+1147% / +827%In 3 years sales changed by +1147% while total assets changed by +827%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-2,635.6×Operating cash was negative last year, while some debt falls due within a year.
Lower than almost all Healthcare companies in United States.
Cash Cushion Ratio
+9%Cash, after subtracting all debt, equals 9% of its market value (net cash).
Lower than 51% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Kestra Medical Technologies, Ltd. made a loss over the last year. Kestra Medical Technologies, Ltd. owes $0.36 for every $1 it owns. Kestra Medical Technologies, Ltd. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Apr 2026.
P/E ratio
LossKestra Medical Technologies, Ltd. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
7.59The share price is 7.59 times Kestra Medical Technologies, Ltd.'s book value per share, higher than 82% of Healthcare companies in United States.
Market cap
$1.7 BThe total market value of all of Kestra Medical Technologies, Ltd.'s shares at today's price (share price × number of shares), larger than 71% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$222 MWhat Kestra Medical Technologies, Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Jul 2026).
Book value per share
$3.73Net worth divided by the number of shares. The share price of $28.32 is 7.6 times this, which is the P/B above.
Return on equity (ROE)
-73.7%Kestra Medical Technologies, Ltd. lost 73.7% of its shareholders' money over the last year, lower than 62% of Healthcare companies in United States.
Owes vs Owns
0.36×Kestra Medical Technologies, Ltd. owes $0.36 for every $1 it owns (low), lower than 55% of Healthcare companies in United States.
Dividend yield
NoneKestra Medical Technologies, Ltd. does not currently pay a dividend.
Revenue growth
+59%Revenue rose 59% in the year to Apr 2026, and grew 132% a year on average over 3 years.
Profit growth
LossKestra Medical Technologies, Ltd. made a loss in each of the last two years.
Profit margin
-138.4%Kestra Medical Technologies, Ltd. lost $138 for every $100 of revenue.
Interest cover
Not coveredKestra Medical Technologies, Ltd.'s operating profit did not cover its interest costs in the year to Apr 2026.
Cash vs debt
Net cashKestra Medical Technologies, Ltd. held $150 M more cash than debt (net cash) at Apr 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Kestra Medical Technologies, Ltd.: $1.7 B ÷ $222 M (31 Jul 2026) = 7.6.
What is Kestra Medical Technologies, Ltd.'s return on equity?
Kestra Medical Technologies, Ltd. lost 73.7% of its shareholders' money over the last year, lower than 62% of Healthcare companies in United States.
How much does Kestra Medical Technologies, Ltd. owe compared with what it owns?
Kestra Medical Technologies, Ltd. owes $0.36 for every $1 it owns (low), lower than 55% of Healthcare companies in United States.
Does Kestra Medical Technologies, Ltd. pay a dividend?
No. Kestra Medical Technologies, Ltd. does not currently pay a dividend.
Is Kestra Medical Technologies, Ltd.'s revenue growing?
Revenue rose 59% in the year to Apr 2026, and grew 132% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.